Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 81-90 of 106 for breast cancer

  • Results filtered:
  • Study status: Open/Status Unknown
Edit search filters
  1. Outcomes and Patient Satisfaction for Patients Admitted to the Mayo Clinic Florida Care Hotel After Mastectomy and Tissue Expander Placement

    Jacksonville, FL

  2. A Study to Evaluate Circulating Tumor DNA (ctDNA) and Immunophenotyping as Potential Biomarkers in Patients Undergoing Regional Nodal Irradiation for Breast Cancer

    Rochester, MN

  3. A Study to Evaluate the Safety of the Goldilocks Procedure with Implant-Based Reconstruction

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  4. Real-time Disease Monitoring of Metastatic Breast Cancer to Optimize Treatment

    Scottsdale/Phoenix, AZ

  5. DiviTum Biomarker Assay for Efficacy in HR+ Metastatic Breast Cancer Patients

    Jacksonville, FL

  6. Ado-trastuzumab emtansine (T-DM1)-Induced Peripheral Neuropathy in HER2-positive Breast Cancer Patients

    Rochester, MN

  7. A Study to Evaluate the Development of Patient Derived Xenografts in Patients With Breast Cancer

    Rochester, MN

  8. A Study to Evaluate the Immune Response to Anti-HER2 Therapies

    Jacksonville, FL

  9. Open Nipple Sparing Mastectomy (NSM)

    Rochester, MN

  10. ACT-MBC: A Study of Circulating Tumor Cells (CTCs) in Metastatic Breast Cancer (MBC) (ACT-MBC)

    Eau Claire, WI, Mankato, MN, Rochester, MN, Albert Lea, MN

.

Mayo Clinic Footer